Boston Scientific Other increased by 21.7% to $505.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 25.3%, from $403.00M to $505.00M. Over 4 years (FY 2020 to FY 2024), Other shows an upward trend with a 12.0% CAGR.
other_other_assets_miscellaneous_current| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $299.00M | $302.00M | $254.00M | $363.00M | $362.00M | $332.00M | $290.00M | $333.00M | $353.00M | $328.00M | $285.00M | $357.00M | $376.00M | $403.00M | $414.00M | $432.00M | $415.00M | $505.00M |
| QoQ Change | — | +1.0% | -15.9% | +42.9% | -0.3% | -8.3% | -12.7% | +14.8% | +6.0% | -7.1% | -13.1% | +25.3% | +5.3% | +7.2% | +2.7% | +4.3% | -3.9% | +21.7% |
| YoY Change | — | — | — | — | +21.1% | +9.9% | +14.2% | -8.3% | -2.5% | -1.2% | -1.7% | +7.2% | +6.5% | +22.9% | +45.3% | +21.0% | +10.4% | +25.3% |